Encycle Therapeutics competitors

Encycle Therapeutics Competitors include Catabasis Pharmaceuticals, Spring Bank Pharmaceuticals, Immupharma and Rezolute.
Add company...
Encycle Therapeutics
Encycle Therapeutics
Encycle Therapeutics is a biopharmaceutical company exploiting a proprietary platform technology that enables the rapid synthesis of small-to-medium macrocycles.
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Immupharma
Immupharma
ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.
Rezolute
Rezolute
Rezolute develops novel therapeutic products for the diabetes market.
Founding Date
Founding Date
2012
Founding Date
2008
Founding Date
2002
Founding Date
N/A
Founding Date
2010
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Toronto, CA HQ
Locations
Cambridge, US HQ
Locations
Hopkinton, US HQ
Milford, US
Locations
London, GB HQ
Mulhouse, FR
Sarnen, CH
Locations
Louisville, US HQ
Employees
Employees
625% decrease
Employees
36
Employees
2140% increase
Employees
10
Employees
20
Valuation ($)
Valuation ($)
N/A
Valuation ($)
309 k
Valuation ($)
161.9 m
Valuation ($)
163.4 m
Valuation ($)
53.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
250
Twitter followers
1.2 k
Twitter followers
350
Twitter followers
147

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$500k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
£150.5k (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($27.4m) (FY, 2017)
Net income
($27.7m) (FY, 2017)
Net income
(£6.2m) (FY, 2017)
Net income
($29.9m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 4.6m
Total funding raised
$ 94.9m
Total funding raised
$ 14.4m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Catabasis Pharmaceuticals
HQ
Cambridge, US
Employees
36

Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.

View company
Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
21↑ 40% increase

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company
Immupharma
HQ
London, GB
Employees
10

ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.

View company
Rezolute
HQ
Louisville, US
Employees
20

Rezolute develops novel therapeutic products for the diabetes market.

View company